Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Northstar Discovers Large Near Surface EM Conductor SE of Cam Copper Mine (click to learn more) Xcyte Digital Corp. Releases "Xperience" Subscription Service (click to learn more) Star Diamond: High Modelled Diamond Prices and High Proportions of Type IIa Diamonds (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum NetraMark Holdings Inc C.AIAI

Alternate Symbol(s):  AINMF

Healthcare Medical Devices
NetraMark Holdings Inc. is a Canada-based company, which is focused on the development of Generative Artificial Intelligence (Gen AI)/Machine Learning (ML) solutions targeted at the pharmaceutical industry. The Company’s product offering uses a novel topology-based algorithm that has the ability to parse patient data sets into subsets of people that are strongly related according to several... see more

CSE:AIAI - Post Discussion

NetraMark Holdings Inc > $MEND 's CSO &Director of Bioinformatics receive award
View:
Post by culturedpiggy01 on Mar 09, 2022 2:53pm

$MEND 's CSO &Director of Bioinformatics receive award

MEND.c ‘s CSO Dr. Joseph Geraci and Director of Bioinformatics, Mike Tsay alongside PhD student Bessi Qorri, Abhishek Agrawal, & Dr. Rhoda Au have received the 'Highly Cited Paper' award from the peer-reviewed journal, Exploration of Medicine https://ca.finance.yahoo.com/news/nurosenes-cso-director-bioinformatics-receives-153800849.html

Their research validates $MEND ‘s AI platform and provides novel insights into Alzheimer's disease (AD, the diagnostics and therapeutics market value of which is estimated at USD $7 Billion. A recognition like this from peers is truly validating, and promotes my faith in the company for sure. congrats to the team!

td, $MEND.c trading at $0.64 with market cap at $25.78 M

 
Be the first to comment on this post
NetraMark Holdings Inc
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities